Skip to content
TrialScanner

NCT04414618

A Study of Opaganib in Coronavirus Disease 2019 Pneumonia

Phase 2CompletedRDHLLead

Registry record

Lead sponsor
RedHill Biopharma Limited
Conditions
Coronavirus Infections
Primary completion
Nov 26, 2020Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04414618 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04414618: A Study of Opaganib in... | TrialScanner